Assume that you work for the Food and Drug Administration. A pharmaceutical company has applied for approval to market a new arthritis medication. The research involved a test group that was given the medication and another test group that was given a placebo.
Respond to the following:
Describe some ways in which the test groups might not be representative of the population of people with arthritis.
If the company itself paid for or conducted its own research, would you have any concerns? Why or why not?
If the study was not conducted as a blind or a double-blind test would you have any concerns? Why or why not?